Therapeutic Indications

Afatinib is indicated for:

Non-small cell lung cancer
and additionally
Non-small cell lung cancer, positive for epidermal growth factor receptor expression

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral